Log in | Register

Log in

Forgot your password?
Not a member?

Home > News

News

First cell-culture based influenza vaccine received WHO Prequalification
Geneva, April 8th 2019 - SKYCellflu Multidose, the cell-culture based influenza vaccine, manufactured by SK bioscience, received World Health Organization (WHO) prequalification. A cell-based flu vaccine was developed as an alternative to the egg-based...
View details
Zydus receives WHO prequalification for Vaxirab – N
Geneva, 07 February 2019 - Vaxirab N, the purified chick embryo cell rabies vaccine manufactured by Zydus Cadila, a leading innovation-driven global healthcare provider, has received prequalification from the World Health Organization (WHO). In 2008, the group...
View details

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | 16

Partners:

DCVMN

DCVMN is a voluntary public health driven alliance of vaccine manufacturers from developing countries that aims to make a consistent supply of high quality vaccines that are accessible to protect people against known and emerging infectious diseases globally.

About us Contact us

Become a member footer

Become a member Register

© 2019DCVMN